Mortality Associated with Breakthrough Candidemia among Patients with and Those without Cancer

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia.

Hematogenous candidiasis adds substantially to the morbidity and mortality rates of patients with cancer. Little is known about the risk factors and outcome in patients with breakthrough (BT) candidemia while on systemic antifungal therapy. All 479 episodes of candidemia in 474 consecutive patients with candidemia that was diagnosed at M. D. Anderson Cancer Center from 1988 through 1992 were st...

متن کامل

Serum cancer antigen 15.3 concentrations in patients with beta-thalassemia minor compared to those with cancer and healthy in-dividuals

  Background :Highserum level of cancer antigen 15.3 (CA15.3) has been reported in some malignant and nonmalignant conditions including thalassemia major which could have been resulted from ineffective erythropoiesis. We aimed to evaluate the serum level of CA15.3 in carriers of beta-thalassemia by comparing them with cancer patients and healthy individuals.   Methods : This cross-sectional stu...

متن کامل

Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia

Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia John W. Baddley,* Mukesh Patel, Sujata M. Bhavnani, Stephen A. Moser, and David R. Andes Department of Medicine, Division of Infectious Diseases, and Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama; Birmingham Veterans Administration Medical Center, Birmingham, Alabama; Insti...

متن کامل

Association of fluconazole pharmacodynamics with mortality in patients with candidemia.

Recent studies of nonneutropenic patients with candidemia or candidiasis suggest that fluconazole pharmacodynamic parameters correlate with clinical outcomes; however, additional data of correlation to mortality in patients with candidemia would be valuable. We assessed the impact of MICs for Candida, fluconazole pharmacodynamics, and patient characteristics on all-cause mortality with use of a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Clinical Infectious Diseases

سال: 2002

ISSN: 1058-4838,1537-6591

DOI: 10.1086/341987